Literature DB >> 22476704

[Diagnosis and therapy of COPD exacerbation].

T T Bauer1, G Nilius, W Grüning, K Rasche.   

Abstract

The acute exacerbation of COPD (AECOPD) is a life-threatening clinical situation. This review summarizes the definition of AECOPD, the severity assessment, typical clinical signs and symptoms, and refers to clinical pitfalls of diagnosis and therapy. Important aspects of clinical history and physical examination in severe exacerbations are reported. The necessary accompanying examinations like chest X-ray, blood gas analysis, ECG and echocardiography and their differential diagnosis as well as therapeutic significance are described. The most important lab examinations are summarized and controversial parameters, e.g., procalcitonin, are commented upon. The differentiated need for a microbiological sputum screening is emphasized. The authors place special weight on the essential components of the therapeutic management of severe AECOPD. Practical aspects of uncontrolled oxygen therapy, drug selection, and application form of inhalative acute therapy, dose, and duration of glucocorticoids, the indication for antibiotics, mechanical ventilation, and also opiates are summarized.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476704     DOI: 10.1007/s00063-011-0065-y

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

2.  European Respiratory Society Guidelines on the use of nebulizers.

Authors:  J Boe; J H Dennis; B R O'Driscoll; T T Bauer; M Carone; B Dautzenberg; P Diot; K Heslop; L Lannefors
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

3.  In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study.

Authors:  Chua Ai-Ping; Kang-Hoe Lee; Tow-Keang Lim
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

4.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

Authors:  S Nouira; S Marghli; M Belghith; L Besbes; S Elatrous; F Abroug
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.

Authors:  R A Stockley; D Bayley; S L Hill; A T Hill; S Crooks; E J Campbell
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

6.  Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.

Authors:  Inmaculada Alía; Miguel A de la Cal; Andrés Esteban; Ana Abella; Ricard Ferrer; Francisco J Molina; Antoni Torres; Federico Gordo; José J Elizalde; Raúl de Pablo; Alejandro Huete; Antonio Anzueto
Journal:  Arch Intern Med       Date:  2011-11-28

7.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  François Maltais; Juliette Ostinelli; Jean Bourbeau; André Bernard Tonnel; Nadine Jacquemet; Jennifer Haddon; Michel Rouleau; Mohamed Boukhana; Jean Benoît Martinot; Pierre Duroux
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

8.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06

9.  Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial.

Authors:  Michael A Austin; Karen E Wills; Leigh Blizzard; Eugene H Walters; Richard Wood-Baker
Journal:  BMJ       Date:  2010-10-18

Review 10.  Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  D C McCrory; C D Brown
Journal:  Cochrane Database Syst Rev       Date:  2002
View more
  2 in total

1.  [Outcome predictors for COPD patients hospitalized for acute exacerbation].

Authors:  M Spielmanns; F Axer; C Nell; A R Koczulla; T Boeselt; F Magnet; J H Storre; W Windisch
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-02       Impact factor: 0.840

2.  Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP.

Authors:  Yuliang Zhao; Fei Li; Yangwen Liu; Yingjun Shi; Zhihai Li; Guangke Cao; Wang Zhu
Journal:  Exp Ther Med       Date:  2018-03-30       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.